Cargando…
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
BACKGROUND: Non-squamous non-small cell lung cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) mutation benefit from targeted treatments. Previous studies reported EGFR mutation-positive proportions among tested non-squamous NSCLC patients. However, incidence rates and population...
Autores principales: | Aye, Phyu Sin, McKeage, Mark James, Tin Tin, Sandar, Khwaounjoo, Prashannata, Elwood, J Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8104366/ https://www.ncbi.nlm.nih.gov/pubmed/33961689 http://dx.doi.org/10.1371/journal.pone.0251357 |
Ejemplares similares
-
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand
por: Aye, Phyu Sin, et al.
Publicado: (2020) -
Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test
por: Shepherd, Phillip, et al.
Publicado: (2017) -
Comparison of Cancer Mortality and Incidence Between New Zealand and Australia and Reflection on Differences in Cancer Care: An Ecological Cross-Sectional Study of 2014-2018
por: Aye, Phyu Sin, et al.
Publicado: (2023) -
Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10
por: Elwood, J. Mark, et al.
Publicado: (2016) -
Cancer of the nasopharynx in Aotearoa New Zealand from 1994 to 2018: Incidence and survival in a population-based, national registry cohort study
por: Minhinnick, Alice, et al.
Publicado: (2022)